Results 131 to 140 of about 21,736 (211)

Iatrogenic hemoperitoneum and sigmoid colon injury from malpositioned apomorphine infusion device in advanced Parkinson's disease. [PDF]

Radiol Case Rep
Hughes C, Fazio T, Umstad C.
europepmc   +1 more source

[Apomorphine].

Neurologia (Barcelona, Spain), 1996
openaire   +3 more sources

Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease. [PDF]

Brain Behav Immun Health
Kang TW, Srinivasan R, Brinkmeyer-Langford C, Welsh CJ.   +3 more
europepmc   +1 more source

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery? [PDF]

, 2013

core   +1 more source

Complexity of fractal dimension patterns and machine learning-based classification of altered motor cortical oscillatory activity in rodent models of Parkinson disease. [PDF]

Front Neurol
Alam M, Abdulbaki A, Armstrong A, Schwabe K, Krauss JK.   +4 more
europepmc   +1 more source

Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors. [PDF]

J Neural Transm (Vienna)
Yegla B, Rubin J, Grall M, Formella A, Jenner P.   +4 more
europepmc   +1 more source

Characterization of [³H]MCL-524, a Potent Dopamine D₂ ^high Receptor Agonist. [PDF]

ACS Omega
Subburaju S, Sromek AW, Seeman P, Neumeyer JL.   +3 more
europepmc   +1 more source

Modulation of Oxidative Stress and Apoptosis by Antrodia cinnamomea-Loaded Citrate-Stabilized Silver Nanoparticles in Experimental Parkinsonism. [PDF]

Mol Neurobiol
Tekiner D, Gedikli S, Gelen V, Bayram C, Kara A.   +4 more
europepmc   +1 more source

Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trial. [PDF]

Brain
Othman MH, Toury-Puel AG, Hansen KIT, Amiri M, Zarifkar P, Peinkhofer C, Stückler SG, Olsen MH, Bjerregaard J, Smitt M, Magnussen AS, Forsse A, Møller J, Nielsen MKK, Jessen CH, Hassager C, Hyttel-Sørensen S, Perner A, Møller MH, Møller-Sørensen PH, Hauerberg J, Birkeland P, Sigurdsson ST, Wamberg CA, Itenov TS, Meyhoff CS, Møller K, Andersen TS, Kjaergaard J, Kondziella D.   +29 more
europepmc   +1 more source

Foslevodopa+foscarbidopa for advanced Parkinson disease. [PDF]

Aust Prescr
europepmc   +1 more source